✦ LIBER ✦

Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice

✍ Scribed by Yoshinori Nio; Michihiko Tsubono; Hideki Morimoto; Kazuya Kawabata; Yoshikazu Masai; Hitoshi Hayashi; Tadao Manabe; Masayuki Imamura; Manabu Fukumoto

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 718 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931215)72:12<3599::aid-cncr2820721209>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitory effects of a cholecystokinin

Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer

✍ Hideki Morimoto; Dr. Yoshinori Nio; Michihiko Tsubono; Chen-Chiu Tseng; Kazuya K 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

The effects of cholecystokinin (CCK) and a CCK antagonist, loxiglumide (CR-1505), on four freshly separated and six xenografted human pancreatic cancers, were investigated. The level of DNA synthesis in only one of five tested pancreatic cancers was enhanced by CCK at concentrations of 0.01-10 nM, w

Cycloprodigiosin hydrochloride, a new H+

Cycloprodigiosin hydrochloride, a new H+/Cl− symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice

✍ Chizuko Yamamoto; Hiroto Takemoto; Kenji Kuno; Daigo Yamamoto; Airo Tsubura; Kei 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB